Dr Krishna Ella
-
Bharat Biotech and Bilthoven Biologicals in collaboration to produce, supply oral polio vaccines
BBIL and BBio will jointly obtain the regulatory approvals and licenses required to commercially manufacture OPVs in India for global…
Read More » -
COVAXIN (BBV152) booster dose study shows promising results
The phase 2, double-blind, randomised controlled COVAXIN trial demonstrated long-term safety with no serious adverse events Bharat Biotech, a global leader in…
Read More » -
IIL produces first lot of Covaxin Drug Substance in record time
Hands over the first consignment of drug substance to Bharat Biotech Dr K Anand Kumar, MD, Indian Immunologicals Ltd (IIL)…
Read More » -
Bharat Biotech demonstrates 100% efficacy against severe COVID-19 disease
Safety and efficacy results from the final analysis will be available in June, and the final report will be submitted…
Read More » -
Bharat Biotech Phase 3 COVAXIN trials show 81 per cent efficacy
Data from 25,800 participants, received vaccine or placebo in a 1:1 ratio showed that the vaccine candidate was well tolerated…
Read More » -
Ukraine Health Minister visits Bharat Biotech vaccine plant
The representatives from the Central Asian nation took a tour of the world-class Bio-Safety Level 3 manufacturing facility in Hyderabad…
Read More » -
Budget reaction: Dr Krishna Ella, CMD, Bharat Biotech and Suchitra Ella, Joint MD, Bharat Biotech
Dr Krishna Ella: It’s a great step ahead, and far-reaching budget announcement, providing ₹35,000 crores for COVID vaccination in 2021-22. The…
Read More » -
SII, Bharat Biotech pledge towards smooth roll-out of COVID-19 vaccines
Both the companies urged to put aside the miscommunication regarding the roll-out of COVID-19 vaccine Serum Institute of India and…
Read More » -
Bharat Biotech International to manufacture vaccines at Odisha unit
10 types of vaccines including malaria and COVID- 19 will be manufactured Hyderabad-based Bharat Biotech International Ltd (BBIL) will manufacture…
Read More »